Navigation Links
Shire's Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
Date:5/7/2008

arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertainties materialize, Shire's results could be materially affected. The risks and uncertainties include, but are not limited to, risks associated with: the inherent uncertainty of pharmaceutical research, product development including, but not limited to the successful development of JUVISTA(R) (Human TGF(beta)3) and velaglucerase alfa (GA-GCB); manufacturing and commercialization including, but not limited to, the establishment in the market of VYVANSE(TM) (lisdexamfetamine dimesylate) (Attention Deficit and Hyperactivity Disorder ("ADHD")); the impact of competitive products, including, but not limited to, the impact of those on Shire's ADHD franchise; patents, including but not limited to, legal challenges relating to Shire's ADHD franchise; government regulation and approval, including but not limited to the expected product approval date of INTUNIV(TM) (guanfacine extended release) (ADHD); Shire's ability to secure new products for commercialization and/or development; and other risks and uncertainties detailed from time to time in Shire plc's filings with the Securities and Exchange Commission, including Shire plc's Annual Report on Form 10-
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase 2a Results for Its First-in-Class Investigational DARA Compound, PS433540
2. Abbotts Phase III Studies of Investigational TriLipix(TM) (ABT-335), in Combination With Statins, Meets Primary Endpoints on Improving LDL, Triglycerides and HDL
3. Study Results Show Investigational Drug, Prasugrel, Cuts Risk of Stent-Related Clots by More than Half Versus Clopidogrel
4. FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
5. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
6. AstraZeneca Completes Enrollment in First Phase III Study of the Investigational Drug Vandetanib (ZACTIMA)(R) in Non-Small Cell Lung Cancer
7. Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
8. SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
9. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
10. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
11. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... , Apr. 17, 2015 Research and Markets ... the "Medical Oxygen Systems - Global Strategic Business ... report analyzes the worldwide markets for Medical Oxygen Systems ... Liquid Oxygen Systems, Oxygen Cylinders & Regulators, and Oxygen ... the US, Canada , ...
(Date:4/17/2015)... , April 17, 2015   IBA Molecular, ... radiopharmaceuticals, announced today that it has signed a definitive ... America, Inc. (IBAM NA), to Illinois Health and Science (IHS). ... as an independent company headquartered in Dulles, ... take advantage of new product and footprint synergies. IBA ...
(Date:4/17/2015)... , April 17, 2015 TWi Pharmaceuticals, Inc. ... TWi Pharmaceuticals USA , has obtained ... United States.  It has been in close contact with ... expects to have its own label specialty generic products ... the U.S. pharma market. According to IMS ...
Breaking Medicine Technology:Medical Oxygen Systems - 2015 Global Strategic Business Report Featuring Leading Players, Caire, Invacare & Philips Respironics 2Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3
... Korea, Nov. 15, 2011 The grand opening ceremony for ... November 10, 2011. RNL BIO ( www.rnl.co.kr ), ... the world,s largest stem cell medical center in Beijing, China. ... "Yanda International Medical Research Institute" (President : Li Hailing, ...
... The new harder to crush version of OxyContin® ... to research revealed at a conference of law enforcement ... and Prevention (CDC) announced that every day 100 people ... involving prescription opioid pain relievers. A new formulation of ...
Cached Medicine Technology:RNL Opens the World's Largest Stem Cell Medical Center in Beijing, China 2New OxyContin® Has Lower Street Price Than Old Crushable Formulation 2
(Date:4/19/2015)... Insurancecarsinsurance.com has released a new blog post making weather ... can affect auto insurance premiums . , ... insurance premiums. In some Northern states like Wisconsin, due ... in other parts. The newly released blog post explains ... months and what impact, if any, it will have ...
(Date:4/19/2015)... McCann Investigations, a Texas-based full services private investigations ... paper Married, but Dating: The Rise of the ... a unique environment of privacy, anonymity and unlimited access, ... spouses has emerged. Social platforms which have been created ... online. Dating sites and mobile apps have found ...
(Date:4/18/2015)... April 19, 2015 For some people, tattoos ... display for the rest of their lives, as they have ... and put in a great amount of thought on their ... they have outgrown them or simply want them removed for ... regret their tattoo, and in 2012-13 there was a 43 ...
(Date:4/18/2015)... April 18, 2015 Carinsurancesavings.biz has released ... plans are cheaper during Spring. , Spring ... insurance plan. Drivers should make sure they compare the ... vehicles. Clients can learn more about Spring car insurance ... , Auto insurance quotes are becoming more and more ...
(Date:4/18/2015)... (PRWEB) April 18, 2015 Review of ... hosting a ‘Strategies for Success’ program for cataract surgeons ... meeting in San Diego, where eye surgeon Jeffrey L. ... this invitation-only event. Dr. Martin is the Managing Partner ... of Ophthalmology chose Dr. Martin to lead this year’s ...
Breaking Medicine News(10 mins):Health News:Bad Weather Can Cause Accidents and Affect Auto Insurance Prices! 2Health News:McCann Investigations Publishes White Paper Married, but Dating: The Rise of the Married Online Affair 2Health News:Dennis Dass, M.D. is Shattering the Past While Revealing the Future 2Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:Dr. Jeffrey Martin Invited to Share Latest Breakthroughs in Cataract Care During Roundtable Discussion at National 2015 ASCRS Meeting In San Diego 2
... DENVER, Feb. 12 The Blue Buffalo ... Connecticut-based,organization dedicated to raising awareness for canine ... to Morris Animal Foundation (MAF) in the,nonprofit,s ... prevent feline cancer.,The Blue Buffalo Foundation has ...
... new low-fat ice cream dipped in chocolate, OAKLAND, ... The Skinny Cow(R) brand urges dieters everywhere to release ... in at just 80 calories per pop, the perfectly-portioned,chocolate-dipped ... and refreshing mint flavors. Skinny Dippers contain no trans ...
... Currently Use Avastin to Treat the Disease, ... Resources, WALTHAM, Mass., Feb. 11 Decision ... advisory firms focusing on,pharmaceutical and healthcare issues, reports ... against Genentech/Roche,s Avastin for,first-line treatment of breast cancer ...
... SAN DIEGO, Feb. 11 SpectraScience, Inc. ... medical devices company, today,announced that it has ... relations consulting firm to provide strategic investor ... of SpectraScience, stated, "We,have selected Hayden Communications ...
... The Office of,Administration today announced it has extended the ... select a new medical plan. The new,plans will become ... health care plan can be difficult, and we,have heard ... their medical options," Secretary of Administration Naomi Wyatt said.,"Therefore, ...
... Feb. 11 AMICAS, Inc. (Nasdaq: AMCS ),a leader in radiology ... company,s financial results,for the fourth quarter and full year ended December 31, ... (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ), WHEN: ... -- Call ...
Cached Medicine News:Health News:The Blue Buffalo Foundation for Cancer Research Sponsors Six Morris Animal Foundation Cancer Studies 2Health News:Dip Your Diet in Chocolate ... Introducing New Skinny Dippers! 2Health News:Despite Oncologists' Willingness to Prescribe Avastin for Treatment of Breast Cancer, the FDA is Likely to Rule Against the Product on February 23 2Health News:SpectraScience, Inc. Retains Hayden Communications 2Health News:Office of Administration Extends Retired State Employees Health Benefits Enrollment Period to March 21 2Health News:AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... Enhanced features including aspiration holes and ... laparoscopic procedures requiring precise dissection with ... increased suction demands. ,Flexible design ... and nonretractable electrodes and multiple tip ...
... aspiration holes and additional electrode tip ... precise dissection with decreased risk of ... ,Flexible design options allow the ... and multiple tip designs. Optimize specific ...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
Medicine Products: